OPINION Inflammation in acute and chronic pancreatitis
INTRODUCTION
Acute pancreatitis is one of the most common gastrointestinal disorders leading to hospital presentation [1] . Common etiologic factors in adults in the United States include alcohol and gallstones. Patients who present with recurrent pancreatic injury or acute pancreatitis are at high risk for developing chronic pancreatitis [2, 3] . Chronic pancreatitis most commonly is associated with alcohol in adults and leads to chronic abdominal pain associated with pancreatic acinar cell loss and fibrosis, which eventually can advance to exocrine and endocrine insufficiency [4, 5] . Although most pancreatic cancer patients have no history of chronic pancreatitis, chronic pancreatitis is a very well known risk factor for pancreatic cancer [6] .
Lack of access to human pancreatic tissue during acute and chronic pancreatitis has made it difficult to obtain full understanding of pathogenic immune mechanisms involved. Nevertheless, animal model studies even with their limitations and the scarce human studies continue to provide tools to advance our understanding of disease pathogenesis. In this review, recent data from animal and when available from human studies are discussed with focus on immune activation and responses. A separate article is dedicated to autoimmune pancreatitis and is not covered here.
INFLAMMATION IN ACUTE PANCREATITIS
There have been several clinical studies that investigated circulating cytokines as predictors and markers of disease severity in acute pancreatitis [7] . Pancreatic acinar cells particularly during the earlier stages of acute pancreatitis produce cytokines such as tumor necrosis factor (TNF)a [8, 9] . These findings were recently corroborated with access to pancreatic acinar cells originating from patients with acute and recurrent acute pancreatitis [10] . In addition, the pancreatic acinar cells from these patients expressed cytokines such as IL-6 and IL-10, and the chemokine monocyte chemoattractant protein-1 (MCP-1; CCL2), suggesting that the initial inflammatory responses and signals that recruit leukocytes originate in injured pancreatic acinar cells.
Neutrophils play an important and pathogenic role in the early phase of acute pancreatitis development as they appear to be the first responder cells recruited to the injury site and contribute to activation of trypsinogen and progression to severe acute pancreatitis [11, 12] . A more recent small study of circulating leukocytes in patients with severe acute pancreatitis with multiorgan dysfunction found aberrant signaling and increased neutrophil transmigration properties [13] , suggesting that neutrophils contribute not only to the early local pancreas events but also to the systemic and end organ damages. Interestingly, a recent study using experimental model of acute pancreatitis found neutrophils to be recruited to the lung quite early and at times similar to that in the pancreas [14 && ]. The pathophysiology for the extra-pancreatic, especially lung, inflammatory responses remain elusive. An elegant recent report, however, showed a pathologic role for IL-6 trans-signaling in promoting the lung injury [15] . Limited cells, mainly hepatocytes and leukocytes, express membrane-bound IL-6 receptor (IL-6R) and IL-6-mediated activation of IL-6R leads to a classic activation [16 & ]. In addition to the membrane-bound IL-6R, there is, however, a soluble IL-6R (sIL-6R) that can target multitude of cells that express the ubiquitous gp130 receptor chain and do not necessarily express membranebound IL-6R [17] . Unlike many other soluble cytokine receptors which act as inhibitors, the sIL-6R bound to IL-6 activates target cells and leads to IL-6 trans-signaling that is distinct from the classic IL-6 activation [16 & ]. Interestingly, IL-6-deficient mice had increased pancreatic damage whereas the lung injury was attenuated, but activation of IL-6 transsignaling worsened both pancreatic and lung injuries suggesting distinct roles for IL-6-classic and IL-6trans-signaling pathways in driving the local versus distant pathologies. The findings also pointed at a possible protective and homeostatic role for IL-6 classical activation in the pancreas, which will need further evaluation. Another notable finding was that myeloid cells were the source for the IL-6-associated lung injury [15] . A soluble protein that blocks IL-6-trans-signaling is currently under clinical trial in other inflammatory diseases [16 & ,18] and may be a promising target for severe acute pancreatitis-associated lung and multiorgan failure.
Tissue injury associated innate immune activation and rapid neutrophil infiltration is usually followed by macrophage recruitment as shown in multiple inflammatory disorders including acute pancreaittis [14 && ,19 && ]. Perhaps related to the later recruitment and long-lasting effects of macrophages relative to neutrophils, most recent inflammationrelated research in acute pancreatitis has focused on macrophages and innate immune signaling pathways. Neutrophils and macrophages play a dual role in inflammation and stimulate repair to allow healing process following injury; however, when such intricate balance is not achieved ongoing inflammation with neutrophils releasing interferon (IFN)g can lead to recruitment of proinflammatory macrophages that impair pancreatic regeneration and promote dedifferentiation of pancreatic epithelium as shown in a cerulein model of acute pancreatitis with or without additional oncogenic stimuli [19 && ,20]. In contrast, a more recent report found a positive role for macrophages in pancreatic regeneration that is dependent on temporally synchronized macrophage polarity [21 && ]. Although different animal models were used in these studies, the findings highlight the functional heterogeneity and plasticity of macrophages during induction and disease progression.
The prognosis of patients with acute pancreatitis strongly correlates with the presence of organ failure and infected pancreatic necrosis [ ] have been implicated as major contributors. Microbial components such as lipopolysaccharide are potent activators of the host innate immune system via pathogen-associated molecular pattern recognition receptors such as toll-like receptors (TLRs). The role of TLR4 in acute pancreatitis was demonstrated previously, in which TLR4deficient mice were protected against local and distant damages [26, 27] . More recent data also showed support for either blocking or inactivating TLR4 using lactate or carbon monoxide in experimentally induced acute pancreatitis [28 && ,29 && ]. Tissue injury also releases endogenous substances referred to as damage-associated molecular pattern molecules, which can serve as TLR ligands and KEY POINTS Acute and chronic pancreatitis are dynamic inflammatory processes.
Immune cells play a critical role in pancreatitis progression.
Endogenous and exogenous signals provide immune cells a mechanism via which they can sense danger and environmental cues.
are being appreciated as important mediators for the pathogenesis of acute pancreatitis. One such molecule is the high mobility group box 1 (HMGB1), which belongs to a protein family of nonhistone nuclear proteins that maintain chromosomal structure and regulate DNA-associated activities [30] . Remarkably, in apoptotic cells HMGB1 binds tightly to chromatin remnants, but in necrotic cells HMGB1 is passively released and triggers inflammatory response [31] . An interesting study using pancreas-specific HMGB1 knockout mouse models showed dual roles for the HMGB1 in which endogenous pancreatic HMBG1 was protective, but extracellular HMGB1 increased severity of acute pancreatitis [32 && ]. Extracellular HMGB1 can activate TLRs and is one mechanism by which damageassociated molecular pattern molecules allow immune activation and sensing of necrotic cells [33, 34] . In support of the above animal studies, a few clinical studies have reported correlation between circulating HMGB1 levels and severity of acute pancreatitis [35, 36] .
IL-33, a recently recognized member of the interleukin 1 superfamily of cytokines, has been coined as an 'alarmin' because of its release during cell injury, and similar to HMGB1 displays dual role as an intracellular nuclear factor and extracellularly as a cytokine by binding to surface receptor ST2 [37, 38] . Soluble IL-33 binds the toll-interleukin 1 receptor domain-containing receptor ST2 and is thought to initiate immune-regulatory effects as well as Th2 immune responses; moreover, a possible counterbalancing activity against proinflammatory effects of IL-1a and HMBG1 has also been suggested for IL-33 [39] . This notion is supported by a recent report of IL-33 promoting regulatory function in the intestine [40 && ]. Although there is limited knowledge with regards to IL-33 and acute pancreatitis, the Lemmers group correlated soluble ST2 (the decoy receptor) levels in plasma of acute pancreatitis patients with parameters of severity [41] . In addition, using ST2-deficient mice, the group showed a protective role for ST2 with a potential regulatory function on mast cell activation during acute pancreatitis. More recently, two groups reported opposing roles for IL-33 in acute pancreatitis. The first report found proinflammatory role for exogenously delivered recombinant IL-33 protein in naive or nonpancreatitis mice in which increased activation of ERK and NF-kB p65 subunit in the pancreas was associated with increased IL-6 and CXCL2 release from acinar cells, and acute inflammation in the pancreas but not in the lung or the jejunum [42] . The group also reported increased pancreatic IL-33 associated with mast cell activation in a distal bilepancreatic duct ligation rodent model of acute pancreatitis, but there were no intervention studies in the pancreatitis model. The second report utilized Coxsackievirus B (CVB) infection model of pancreatitis and also found elevated pancreatic IL-33 post infection; however, exogenous IL-33 administration conferred protection and reduced viral titers [43] . In this study, ST2-deficient mice had decreased number of mast cells and were highly susceptible to CVBinduced pancreatic damage and necrosis. Interestingly, adoptive transfer of wild-type mast cells or alternatively activated macrophages (M2s) post infection protected the ST2-deficient mice from CVB-induced pancreatitis despite no alteration in viral load, which may suggest the protective role of IL-33 signaling in this model to be mediated in part via the well defined wound healing and reparative roles of M2s. This was also consistent with the authors' observation that the adoptive transfer of mast cells was associated with an increase in pancreas M2 and regulatory T-cell markers. The opposing roles of IL-33 reported by these two groups in the pancreas may relate to differences in models studied and the complex dual functions of IL-33 [44] that may be context dependent, an area that will require further investigation with simultaneous examination of the cytokine and its receptors (ST2 and soluble ST2) in patients and different models of acute pancreatitis.
INFLAMMATION IN CHRONIC PANCREATITIS
As mentioned in the above, recurrent acute pancreatitis patients have a very high risk of developing chronic pancreatitis; for this reason, experimental models of chronic pancreatitis have relied on repetitive injury. Notable histologic features in chronic pancreatitis include acinar cell atrophy, chronic inflammation, distorted or blocked ducts and invariably pancreatic stellate cell (PSC) activation associated with pancreatic fibrosis [5, 45] . Earlier animal and human studies showed T cells and macrophages to be the predominant immune cell infiltrates in chronic pancreatitis [46] [47] [48] . A role for T cells in chronic pancreatitis has been proposed [49, 50] . A potential role for macrophages in chronic pancreatitis was also proposed based on histologic observation of their close proximity to PSCs [51, 52] . More recently, a study using cerulein model of chronic pancreatitis and human primary PSC-macrophage cocultures defined a pathogenic role for alternatively activated macrophages (M2) and IL-4 receptor (IL-4R)a signaling [53] . Unlike in acute pancreatitis in which M1s predominate, pancreas from mouse and human chronic pancreatitis were infiltrated with M2s. In addition, both mouse and human PSCs were a source for IL-4Ra ligands and promoted M2 polarization. The M2s, in turn, were efficient at activating the PSCs, prompting a 'feed-forward' process that pointed to a critical role for macrophages in pancreatic fibrosis. Notably, pancreatic fibrosis was reduced in mice with myeloid-specific IL-4Ra deletion or mice receiving pharmacologic inhibitor of IL-4Ra following established disease. Furthermore, human and mouse PSC-driven M2 polarization was also inhibited with pharmacologic IL-4Ra blockade. Thus, interfering with M2 polarization by targeting IL-4Ra signaling offers a potential mechanism for limiting fibrogenesis in chronic pancreatitis.
Host-microbiome interaction has been a central research topic over the past few years in health and disease. Research in microbiome and pancreatic disease is, however, still at its infancy. Farrell et al. [54] using the Human Oral Microbe Identification Microarray noted alteration in salivary microbiota in patients with pancreatic cancer and chronic pancreatitis as compared with healthy study participants. Whether these microbial alterations are confined to the oral mucosa or extend to the intestinal flora and how they relate to pathophysiology in the pancreas remain to be clarified. More recently, Neurath's group presented an oral abstract at the Digestive Disease Week May 2014 meeting, in which experimental pancreatitis induced via forced expression of IL-17A in the liver of C57BL/6 was microbiota dependent [55 & ]. They reported that institution-reared C57BL/6, unlike industry-purchased C57BL/6, developed chronic pancreatitis following over-expression of the IL-17A. Interestingly, in the same model, the industry-purchased mice developed chronic pancreatitis only following oral gavage of feces derived from their institutionderived mice, suggesting that the microbiota contributed to the pathogenesis of the IL-17A-induced chronic pancreatitis. Although very limited data are available, further investigations will be awaited eagerly as microbiome-related research resources are becoming more widely available and fecal microbiota transplant is becoming a widely accepted therapeutic option in different gastrointestinal diseases [56,57,58 & ].
CONCLUSION
The recent reports highlight the dynamic nature of inflammatory responses associated with acute and chronic pancreatitis. Timing is key and better diagnostic tools and biomarkers correlative to local and distant inflammatory signals need to be developed in order to prevent and target disease progression. Immune cells are critical in pancreatitis and have the ability to sense microenvironment, and respond to danger signals derived from endogenous and exogenous molecules. Further in-depth study of environmental cues and immune responses in human and animal models is likely to improve our understanding of disease pathogenesis and offer means to change the unfavorable outcomes associated with the natural course of the acute and chronic pancreatitis. This study finds significant correlation hypotension and APACHE II score early during admission with acute pancreatitis with developing infected pancreatic necrosis. 25.
